Articles tagged "Liver transplantation"

2019 American Transplant Congress
Pregnancy Outcomes by Conception Age in Female Liver Transplant Recipients
M. Sarkar¹, L. A. Coscia², D. Kliniewski², S. Rao³, S. Constantinescu⁴, M. J. Moritz⁵
¹Medicine, University of California San Francisco, San Francisco, CA, ²Gift of Life Institute, Transplant Pregnancy Registry International, Philadelphia, PA, ³Medicine, University of Virginia Health System, Charlottesville, VA, ⁴Lewis Katz School of Medicine, Temple University, Philadelphia, PA, ⁵Surgery, Lehigh Valley Health Network, Allentown, PA
*Purpose: The purpose of this study is to compare pregnancy outcomes in liver transplant recipients by different conception ages. Background: Over 30% of female transplant…
2019 American Transplant Congress
Barriers to Pre-Transplant Immunization: A Qualitative Study of Pediatric Liver-Transplant Stakeholders
A. G. Feldman¹, R. Marsh², A. Kempe³, M. Morris²
¹Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado, Aurora, CO, ²University of Colorado, Aurora, CO, ³Pediatrics, University of Colorado, Aurora, CO
*Purpose: Less than 30% of pediatric liver transplant recipients are up-to-date on age-appropriate immunizations at the time of transplant despite being at high-risk for infections…
2019 American Transplant Congress
Recipient Myeloid Notch1 Disruption Shifts Neutrophil towards Anti-Inflammatory Phenotype and Protects Liver Grafts from Ischemia-Reperfusion Injury
S. Kageyama¹, H. Hirao¹, K. Kadono¹, K. Nakamura¹, K. J. Dery¹, T. Ito², D. Oncel¹, J. Aziz¹, B. Ke¹, F. M. Kaldas², R. W. Busuttil², J. W. Kupiec‐Weglinski¹
¹Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA, ²Surgery, Ronald Reagan UCLA Medical Center, UCLA, Los Angeles, CA
*Purpose: Liver ischemia-reperfusion injury (IRI) represents a major risk factor of early graft dysfunction and predisposes to rejection crises in orthotopic liver transplantation (OLT). We…
2019 American Transplant Congress
Hepatocyte SIRT1 Modulates ATF4/CHOP and Mitigates Liver Transplant Ischemia-Reperfusion Injury: From Bench-to-Bedside
H. Hirao¹, S. Kageyama¹, K. Kadono¹, K. Nakamura¹, T. Ito¹, K. J. Dery¹, D. Oncel¹, X. Li², B. Ke¹, F. M. Kaldas¹, R. W. Busuttil¹, J. W. Kupiec‐Weglinski¹
¹Surgery, Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA, ²National Institute of Environmental Health Sciences, Research Triangle Park, NC
*Purpose: We and others have reported on benefits of endoplasmic reticulum (ER) stress modulation against hepatic ischemia-reperfusion injury (IRI) in orthotopic liver transplantation (OLT). Although…
2019 American Transplant Congress
The Comparative Safety and Efficacy of Direct Acting Oral Anticoagulants Relative to Warfarin Following Liver Transplantation
A. Santeusanio, A. Weinberg, T. Schiano
Mount Sinai Hospital, New York, NY
*Purpose: This study describes the comparative safety and efficacy of direct acting oral anticoagulants (DOACs) relative to warfarin following liver transplantation, at a large academic…
2019 American Transplant Congress
Impact of Coronary Artery Disease on Long-Term Mortality after Liver Transplantation
S. S. Patel¹, V. A. Rodriguez², M. B. Siddiqui¹, J. Laurenzano³, F. Lin³, J. Clinton³, M. Faridnia⁴, A. Chandrakumaran⁴, T. Reichman⁵, C. Bhati⁵, M. S. Siddiqui¹
¹Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, ²Department of Bio-statistics, Virginia Commonwealth University, Richmond, VA, ³Virginia Commonwealth University, Richmond, VA, ⁴Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, ⁵Department of Transplant Surgery, Virginia Commonwealth University, Richmond, VA
*Purpose: Cardiovascular disease (CVD) is an important cause of post liver transplantation (LT) mortality and is higher than age-and gender matched cohorts. This happens despite…
2019 American Transplant Congress
Impact of Recipient Age in Combined Liver-Kidney Transplantation (CLKT): Caution is Needed for Elderly Patients≥70 Years
B. Ekser¹, W. C. Goggins¹, R. S. Mangus¹, P. Mihaylov¹, J. A. Fridell¹, M. A. Lacerda², M. S. Ghabril², J. A. Powelson¹, C. A. Kubal¹
¹Transplant Division, Department of Surgery, Indiana University, Indianapolis, IN, ²Gastroenterology, Indiana University, Indianapolis, IN
*Purpose: Recent SRTR analysis showed that elderly recipients (≥70 years) accounts for 2.6% of all liver transplant alone (LTA) and do as well as younger…
2019 American Transplant Congress
Effectiveness Of The Vittal Viability Criteria During Ex Situ Normothermic Machine Perfusion To Discriminate Hepatobiliary Organ Injury And Investigation Of Biochemical Markers For Post-transplant Complications
Y. L. Boteon, R. Laing, J. Attard, L. Wallace, A. Smith, M. Perera, D. Mirza, H. Mergental, S. Afford
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom
*Purpose: The VITTAL (viability testing and transplantation of marginal livers) clinical trial demonstrated that ex situ end-ischaemic normothermic machine perfusion (NMP) allows functional assessment and…
2019 American Transplant Congress
Comparable Outcomes of Deceased Donor Liver Transplant Outcomes in Recipients with Previous Abdominal Surgery (PAS) after Pre Listing Surgical Categorization. A Propensity-Score Matched Pair Analysis
H. Sharma, H. Bohorquez, D. Oganesyan, D. Bruce, E. Bugeaud, I. Carmody, A. Cohen, J. Seal, D. Sonnier, G. Loss
Department of Transplant Surgery, Ochsner Medical Center, New Orleans, LA
*Purpose: Few studies have evaluated the impact of previous abdominal surgery (PAS) on deceased donor liver transplantation-(DDLT). Furthermore, there is no evidence of impact of…
2019 American Transplant Congress
Evaluation of Pneumocystis jirovecii Pneumonia Prophylaxis among Kidney and Liver Transplant Recipients; Trimethoprim/Sulfamethoxazole vs Alternative Therapies
E. Aldag, C. Pagels, R. Pedersen, I. Nadeem, V. Gunabushanam, A. Sahajpal, T. J. Dilworth
Aurora St Luke's Medical Center, Milwaukee, WI
*Purpose: To describe Pneumocystis Jirovecii Pneumonia (PJP) prophylaxis (ppx) practices in our transplant recipients and to determine its safety and efficacy.*Methods: Retrospective review of kidney…